financetom
Business
financetom
/
Business
/
F3 Uranium Details Latest Assays from JR Discovery in Canada
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
F3 Uranium Details Latest Assays from JR Discovery in Canada
Jun 12, 2024 5:29 AM

08:10 AM EDT, 06/12/2024 (MT Newswires) -- F3 Uranium ( FUUFF ) on Wednesday reported assays from 15 drill holes from the 2024 winter drilling program at the new JR uranium discovery within the Patterson Lake North property in Canada's Athabasca Basin.

Results from drill hole PLN24-116 include 12.0 meters of 7.6% uranium, including a high-grade 8.0-meters interval averaging 11.2% uranium, further including an ultra-high grade core of 2.0 meters of 31.4% uranium.

"We are very pleased with the results of the ongoing exploration program, in particular the area around the southern end of A1 where our geological targeting model is improving," said Sam Hartmann, F3's vice president for exploration.

The company's share price dropped 4.3% yesterday to $0.335.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
SPAC backed by Trump Jr., Omeed Malik files for $260 million US IPO
SPAC backed by Trump Jr., Omeed Malik files for $260 million US IPO
Oct 17, 2025
Oct 17 (Reuters) - Colombier Acquisition Corp. III, a blank-check firm backed by Omeed Malik, filed for an initial public offering in the United States on Friday. The Palm Beach, Florida-based company plans to offer 26 million shares priced at $10 each and is seeking to raise $260 million. Donald Trump Jr. is one of the directors and has served...
Sionna Therapeutics Insider Sold Shares Worth $788,153, According to a Recent SEC Filing
Sionna Therapeutics Insider Sold Shares Worth $788,153, According to a Recent SEC Filing
Oct 17, 2025
05:18 PM EDT, 10/17/2025 (MT Newswires) -- Michael Cloonan, Director, President & CEO, on Oct. 15 and Oct. 16, sold 25,200 shares in Sionna Therapeutics ( SION ) for $788,153. Following the Form 4 filing with the SEC, Cloonan has control over a total of 547,343 shares of the company, with 547,343 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/2036042/000170433625000006/xslF345X05/edgardoc.xml ...
Breach at US-based cybersecurity provider F5 blamed on China, sources say
Breach at US-based cybersecurity provider F5 blamed on China, sources say
Oct 17, 2025
(This October 16 story is repeated without any changes to the text.) By AJ Vicens and Raphael Satter (Reuters) -A breach at U.S.-based cybersecurity company F5 has been blamed on state-backed hackers from China, two people briefed on the investigation said on Thursday. On Wednesday, U.S. government officials said federal networks are being targeted by an unidentified nation-state cyber threat...
BRIEF-BillionToOne expects IPO price between $49 and $55 per share - SEC filing
BRIEF-BillionToOne expects IPO price between $49 and $55 per share - SEC filing
Oct 17, 2025
Oct 17 (Reuters) - BillionToOne Inc: * BILLIONTOONE INC - IPO PRICE EXPECTED BETWEEN $49.00 AND $55.00 PER SHARE - SEC FILING * BILLIONTOONE INC SEES IPO OF 3.8 MILLION SHARES OF CLASS A COMMON STOCK - SEC FILING Source text: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved